TY  - GEN
AU  - Seki,R
AU  - Ohshima,K
AU  - Fujisaki,T
AU  - Uike,N
AU  - Kawano,F
AU  - Gondo,H
AU  - Makino,S
AU  - Eto,T
AU  - Moriuchi,Y
AU  - Taguchi,F
AU  - Kamimura,T
AU  - Tsuda,H
AU  - Shimoda,K
AU  - Okamura,T
TI  - Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab
SN  - 1569-8041
PY  - 2010///0622
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Cyclin-Dependent Kinase Inhibitor p27
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - diagnosis
KW  - Male
KW  - Middle Aged
KW  - Prednisone
KW  - Prognosis
KW  - Retrospective Studies
KW  - Rituximab
KW  - S-Phase Kinase-Associated Proteins
KW  - Survival Analysis
KW  - Vincristine
KW  - Young Adult
N1  - Publication Type: Evaluation Study; Journal Article
UR  - https://doi.org/10.1093/annonc/mdp481
ER  -